文献速递心血管US

外科手术禁忌风险的退行性二尖瓣反流患者经导管缘对缘修复的超声心动图结局

Echocardiographic Outcomes With Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-12-13

CLASP IID随机试验评估PASCAL系统在外科手术禁忌的显著症状性退行性二尖瓣反流患者中的超声心动图结局,180例随机患者中PASCAL组117例、MitraClip组63例。出院时所有患者均达到MR≤2+,MR≤1+比例两组出院时相似但6个月时出现差异,偏向PASCAL组(83.7% vs 71.2%)。较小的连枷间隙与出院时达到MR≤1+显著相关(校正OR:0.70;95%CI:0.50-0.99),PASCAL治疗和较小连枷间隙与6个月维持MR≤1+显著相关(校正OR分别为2.72和0.76;95%CI:1.08-6.89和0.60-0.98)。

要点

  • 出院时全部患者达到MR≤2+,6个月时PASCAL组MR≤1+比例83.7%高于MitraClip组71.2%。
  • 较小的连枷间隙与出院时达到MR≤1+显著相关(校正OR:0.70;95%CI:0.50-0.99)。
  • PASCAL治疗和较小连枷间隙是6个月维持MR≤1+的显著因素。

核心结论

  • PASCAL治疗和较小的连枷间隙是6个月维持MR≤1+的显著因素,MR≤1+是成功M-TEER可达到的基准。

研究设计与样本

  • CLASP IID随机试验的超声心动图分析,180例随机患者(PASCAL组n=117,MitraClip组n=63),由独立超声心动图核心实验室依据美国超声心动图学会指南评估MR机制、严重程度和M-TEER可行性。

关键影像表现/征象

  • 基线连枷瓣叶存在于79.2%的患者中。
  • 基线MR为4+者占76.4%,3+者占23.6%。
  • 出院时全部患者达到MR≤2+。

诊断标准与关键数值

  • 出院时MR≤1+比例两组相似,6个月时PASCAL组83.7% vs MitraClip组71.2%。
  • 较小连枷间隙与出院时达到MR≤1+显著相关(校正OR:0.70;95%CI:0.50-0.99)。
  • PASCAL治疗与6个月维持MR≤1+显著相关(校正OR:2.72;95%CI:1.08-6.89)。
  • 较小连枷间隙与6个月维持MR≤1+显著相关(校正OR:0.76;95%CI:0.60-0.98)。

临床应用与阅片要点

  • 采用针对退行性二尖瓣反流的超声心动图方法评估MR机制、严重程度和M-TEER可行性,反映当前指南和三维超声心动图进展。
  • 基线连枷间隙较小可能提示更易达到并维持MR≤1+。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The CLASP IID randomized trial (Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial) demonstrated the safety and effectiveness of the PASCAL system for mitral transcatheter edge-to-edge repair (M-TEER) in patients at prohibitive surgical risk with significant symptomatic degenerative mitral regurgitation (DMR).

OBJECTIVES: This study describes the echocardiographic methods and outcomes from the CLASP IID trial and analyzes baseline variables associated with residual mitral regurgitation (MR) ≤1+.

METHODS: An independent echocardiographic core laboratory assessed echocardiographic parameters based on American Society of Echocardiography guidelines focusing on MR mechanism, severity, and feasibility of M-TEER. Factors associated with residual MR ≤1+ were identified using logistic regression.

RESULTS: In 180 randomized patients, baseline echocardiographic parameters were well matched between the PASCAL (n = 117) and MitraClip (n = 63) groups, with flail leaflets present in 79.2% of patients. Baseline MR was 4+ in 76.4% and 3+ in 23.6% of patients. All patients achieved MR ≤2+ at discharge. The proportion of patients with MR ≤1+ was similar in both groups at discharge but diverged at 6 months, favoring PASCAL (83.7% vs 71.2%). Overall, patients with a smaller flail gap were significantly more likely to achieve MR ≤1+ at discharge (adjusted OR: 0.70; 95% CI: 0.50-0.99). Patients treated with PASCAL and those with a smaller flail gap were significantly more likely to sustain MR ≤1+ to 6 months (adjusted OR: 2.72 and 0.76; 95% CI: 1.08-6.89 and 0.60-0.98, respectively).

CONCLUSIONS: The study used DMR-specific echocardiographic methodology for M-TEER reflecting current guidelines and advances in 3-dimensional echocardiography. Treatment with PASCAL and a smaller flail gap were significant factors in sustaining MR ≤1+ to 6 months. Results demonstrate that MR ≤1+ is an achievable benchmark for successful M-TEER. (Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial [CLASP IID]; NCT03706833).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Marcoff L, Koulogiannis K, Aldaia L, et al. Echocardiographic Outcomes With Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients. JACC Cardiovasc Imaging. 2023. PMID: 38099912. doi:10.1016/j.jcmg.2023.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。